Speciality Oncologist
Qualifications MBBS, DNB, D.M.
Areas of Expertise Chemotherapy and Immunotherapy
Languages English, Hindi, Telugu

Dr Harshavardhan Annadanam



Dr HarshavardhanAnnadanamis the Best Oncologist and Chemotherapy specialist in HITEC City, Hyderabad.

Dr HarshavardhanAnnadanam, MBBS, DNB, D.M. Medical Oncologist, Chemotherapy Specialist, proficient haematologist, certified in bone marrow transplant.

He is a specialist in handling chemotherapy solid tumours and an expert in Oncology, Acute lymphoblastic lymphoma, haematological malignancies.

He treats cancer patients based on his/her cancer cell condition.
Dr Harshavardhan Annadanam is known for his palliative care, counselling patients and their family.

Education Qualifications:
1. He completed MBBS in the Date April 2008 from Kurnool Medical College -Kurnool, Dr.N.T.R University of Health Sciences, Andhra Pradesh.
2. After MBBS, he did DNB (General Medicine) from the Date December 2016, Awarded from National Board of Examinations, NEW DELHI
3. DM (Medical Oncology) was Completed by August 2021 from the Center of study – Gujarat Cancer Research Institute (GCRI), B.J. Medical College, Ahmedabad, Gujarat
4. Received MEDICAL COUNCIL REGISTRATION, Gujarat Medical council, Register number G72432
5. Received Andhra Pradesh, Medical Council, Register number 63680

Professional Experience:
1. Consultant Medical Oncologist at Medicover Hospital, HITEC City
2. Medical Oncology resident at Gujarat Cancer Research Institute
3. Registrar at Apollo Main Hospital, Chennai, Tamilnadu
4. Senior Resident at Apollo Main Hospital, Chennai
5. Junior Resident at Apollo Main Hospital, Chennai

Professional Expertise and Skills
1. Teaching the postgraduate doctors at the Institute.
2. Comprehensive management of cancer patients including advice on the necessity of chemotherapy and radiation as indicated and referral for other specialists as required.
3. Chemotherapy of solid tumours – regimen selection, dose calculation, administration, toxicity monitoring, and response reassessment
4. Proficient in haematological malignancies, administering chemotherapy to patients (IV, oral, intrathecal), high and low dose rate chemotherapy, daycare chemotherapy, bone marrow aspiration, trust biopsy, ascitic and pleural tapping, etc.
5. Attending Tumor board discussions and other academic sessions.
6. Managing outpatient clinics and taking care of ward patients.
7. History taking and clinical examination.
8. Attending calls on a rotational basis.
9. Management of common radiation and chemo-induced complications.
10. Counselling of patients and family members.
11. Research – data collection (using SPSS and Microsoft excel), analysis, and manuscript preparation.

Poster & Case Presentations
1. Finalist of Prestigious Torrent Young Scholar Award – TYSA (Medical Oncology), December 2020.
2. Winner of Zonal Round of prestigious Torrent Young Scholar Award-TYSA (Medical Oncology), Jaipur, October 2019. Received “The Best Resident award” in the Department of General Medicine for the year 2015 at Apollo Main Hospital, Chennai.
3. Poster presentation titled “CLINICAL PROFILE OF DIFFUSE LARGE B CELL LYMPHOMA” – ISMPOCON 2020 held at Bengaluru, India.

Training Attended
1. Apollo cancer conclave and Cancer C . February 2020. Hyderabad.
2. Symposium on acute lymphoblastic lymphoma. Feb 2020. Ahmedabad.
3. QURE Hematology conference 2020. 18-19 Jan 2020, Ahmedabad.
4. 2nd Uro oncology update. November 24, 2019. Ahmedabad.

Conferences Attended
1. JIC Oncology symposium. Ahmedabad. January 4-6 2019
2. Annual conference of Indian Society of Electro cardiology - ISKCON 2016, APICON 2016, Hyderabad
3. Annual conference of Indian Academy of Neurology – IANCON, October 2015, Agra.
4. International meeting of clinical practice guidelines in Oncology and Indian perspectives in December 2014, Chennai.
5. International meeting of clinical practice guidelines in Oncology – 2014 and Indian perspectives in December 2014, Chennai.
6. Apollo Infectious disease conference in July 2014.
7. CME conducted by the Endocrine Society – TRENDO, July 2014.

Publications :
1. Nivolumab in recurrent/metastatic squamous cell carcinoma of head and neck: A tertiary cancer center experience. Ananya Pareek, Apurva Patel, Mohammed Nasir, Philip George Kuttikat, A Harshavardhan et al. South Asian Journal of cancer 2020 (Ahead of print)
2. Topotecan plus cyclophosphamide as a salvage regimen in patients with relapsed/refractory pediatric type tumors. Philip George Kuttikat, Apurva A Patel, Ananya Pareek, Shantanu Pendse, A Harshavardhan, et al. International Journal of current research. 2021/13(04):16901-16905.